Şeyda Kaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Şeyda Kaya has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Sevgi Durna Daştan
Sivas Cumhuriyet University
3 shared publications - İnanc Baral
Sivas Cumhuriyet Üniversitesi
2 shared publications - Mustafa Murat Öztürk
Kirsehir Ahi Evran Universitesi
2 shared publications - Sevgi Durna Daştan
Sivas Cumhuriyet Üniversitesi
2 shared publications - Taner Daştan
Sivas Cumhuriyet Üniversitesi
2 shared publications - Dilek Arslan Atessahin
Fırat University, Baskil Vocational School, Department of Plant and Animal Production, 23800, Elazig, Turkey
1 shared publication
Latest Publications
- 29 June 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (3) , 427-437
Molecular Perspective on Pancreatic Cancers with a Focus on Genetics, Genomics, and Diagnostics
The pancreas stands out as a complicated organ vital for maintaining physiological balance with its exocrine and endocrine roles. It is aimed to present the genetic underpinnings of working basis of pancreas and its diseases with related biochemical pathways, especially with a focus on pancreatic cancers (PC). This article collects all current research and filters data about pancreatic biology and the molecular genetic backgrounds, and genomics pathways related pancreatic diseases. The pancreas has the highest number of different genetic disorders, which are always multifactorial. The pancreatic adenocarcinoma are particularly significant due to their rapid metastatic potential, extreme lethality, and surprising mortality rates. Various studies have revealed the different causes of the development of pancreatic cancers. And it is seen that it may be both a somatic and hereditary type of cancer. Some very important research has emphasised a substantial but insufficient network of gene-phenotype relationships for several mutations and susceptibility loci. This article collects the detailed perspective about existing literature to underline the molecular view of pancreatic cancers based on genetic, genomic and diagnostic principles. This article focus on isolated aspects such as genomics or diagnostics, this review provides an integrated perspective combining molecular genetics, genomic instability, and emerging diagnostic approaches. By synthesizing findings across multiple disciplines, this study highlights the importance of a systems-level understanding of pancreatic cancer and proposes a framework for future research directions.
- 29 June 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (3) , 427-437
Molecular Perspective on Pancreatic Cancers with a Focus on Genetics, Genomics, and Diagnostics
The pancreas stands out as a complicated organ vital for maintaining physiological balance with its exocrine and endocrine roles. It is aimed to present the genetic underpinnings of working basis of pancreas and its diseases with related biochemical pathways, especially with a focus on pancreatic cancers (PC). This article collects all current research and filters data about pancreatic biology and the molecular genetic backgrounds, and genomics pathways related pancreatic diseases. The pancreas has the highest number of different genetic disorders, which are always multifactorial. The pancreatic adenocarcinoma are particularly significant due to their rapid metastatic potential, extreme lethality, and surprising mortality rates. Various studies have revealed the different causes of the development of pancreatic cancers. And it is seen that it may be both a somatic and hereditary type of cancer. Some very important research has emphasised a substantial but insufficient network of gene-phenotype relationships for several mutations and susceptibility loci. This article collects the detailed perspective about existing literature to underline the molecular view of pancreatic cancers based on genetic, genomic and diagnostic principles. This article focus on isolated aspects such as genomics or diagnostics, this review provides an integrated perspective combining molecular genetics, genomic instability, and emerging diagnostic approaches. By synthesizing findings across multiple disciplines, this study highlights the importance of a systems-level understanding of pancreatic cancer and proposes a framework for future research directions.
- Open Access
- 30 March 2026
- Published by Wah Academia (SMC-PVT) Ltd in Wah Academia Journal of Health and Nutrition
- Vol. 2 (1) , 99-107
Database-sourced Virulence Factor Comparison between strains of Chlamydia trachomatis and Neisseria gonorrhoeae
According to the predictions of the World Health Organization, Chlamydia trachomatis and Neisseria gonorrhoeae were two of the most prominent pathogenic bacteria responsible for increasing emergence of sexually transmitted infections. These two bacteria were repeatedly reported as the most serious challenges in public health problems. Both bacteria have similar infection sites and clinical synopses, and reported for co-infections, despite the fact of being from distinct phyla and having distinct life-cycles. Extensive research revealed diverse array of virulence factors for these bacteria, and each of them having different classes of virulence factors appropriate for its life-cycle and survival. In this research curated strains of C. trachomatis and N. gonorrhoeae present in the Virulence Factor Database of the National Institute of Pathogen Biology in China were used for proteome-based intra-genera comparison, which revealed virulence factor class distinctness between the two species. Comparisons were revealed strain uniformity in C. trachomatis but strain variation in N. gonorrhoeae along with pronounced genetic complexity in N. gonorrhoeae virulance factors. However, obtained results revealed absences of related genes for virulance factors in C. trachomatis despite the presence of coding sequences in strains, and absences of coding sequences in N. gonorrhoeae FA 1090 strain. Results also revealed limited amount of virulence factor classes for C. trachomatis contrary to extensive literature reports and multigenic factors in certain virulence factors in N. gonorrhoeae strains due to the presence of multiple coding sequences. Overall, this research was revealed potential targets for further genomics research and emphasized the need of embracing multi-omics approaches in clinical microbiology studies. Dünya Sağlık Örgütü'nün tahminlerine göre, Chlamydia trachomatis ve Neisseria gonorrhoeae, cinsel yolla bulaşan enfeksiyonların artan yaygınlığından sorumlu en önemli patojenik bakterilerden ikisidir. Bu iki bakteri, halk sağlığı sorunlarında en ciddi zorluklar olarak defalarca rapor edilmiştir. Her iki bakteri de benzer enfeksiyon bölgelerine ve klinik özetlere sahiptir ve farklı filumlardan olmalarına ve farklı yaşam döngülerine sahip olmalarına rağmen, birlikte enfeksiyonlar için rapor edilmiştir. Kapsamlı araştırmalar, bu bakteriler için çeşitli virülans faktörlerini ortaya koymuş ve her birinin yaşam döngüsüne ve hayatta kalmasına uygun farklı virülans faktörü sınıflarına sahip olduğunu göstermiştir. Bu araştırmada, Çin'deki Ulusal Patojen Biyolojisi Enstitüsü'nün Virülans Faktörü Veritabanı'nda bulunan C. trachomatis ve N. gonorrhoeae'nin seçilmiş suşları, proteom tabanlı cins içi karşılaştırma için kullanıldı ve bu da iki tür arasında virülans faktörü sınıfı farklılığını ortaya çıkardı. Karşılaştırmalar, C. trachomatis'te suş homojenliğini, N. gonorrhoeae'de ise suş varyasyonunu ve N. gonorrhoeae virülans faktörlerinde belirgin genetik karmaşıklığı ortaya koydu. Ancak elde edilen sonuçlar, suşlarda kodlama dizilerinin varlığına rağmen C. trachomatis'te virülans faktörleriyle ilgili genlerin bulunmadığını ve N. gonorrhoeae FA 1090 suşunda kodlama dizilerinin bulunmadığını ortaya koymuştur. Sonuçlar ayrıca, kapsamlı literatür raporlarının aksine C. trachomatis için sınırlı sayıda virülans faktörü sınıfı ve N. gonorrhoeae suşlarında birden fazla kodlama dizisinin varlığı nedeniyle bazı virülans faktörlerinde çok genli faktörler olduğunu göstermiştir. Genel olarak, bu araştırma, daha ileri genomik araştırmalar için potansiyel hedefleri ortaya koymuş ve klinik mikrobiyoloji çalışmalarında çoklu omik yaklaşımların benimsenmesinin gerekliliğini vurgulamıştır.
- 30 March 2026
- Published by Wah Academia (SMC-PVT) Ltd in Wah Academia Journal of Health and Nutrition
- Vol. 2 (1) , 99-107
Open AccessDatabase-sourced Virulence Factor Comparison between strains of Chlamydia trachomatis and Neisseria gonorrhoeae
According to the predictions of the World Health Organization, Chlamydia trachomatis and Neisseria gonorrhoeae were two of the most prominent pathogenic bacteria responsible for increasing emergence of sexually transmitted infections. These two bacteria were repeatedly reported as the most serious challenges in public health problems. Both bacteria have similar infection sites and clinical synopses, and reported for co-infections, despite the fact of being from distinct phyla and having distinct life-cycles. Extensive research revealed diverse array of virulence factors for these bacteria, and each of them having different classes of virulence factors appropriate for its life-cycle and survival. In this research curated strains of C. trachomatis and N. gonorrhoeae present in the Virulence Factor Database of the National Institute of Pathogen Biology in China were used for proteome-based intra-genera comparison, which revealed virulence factor class distinctness between the two species. Comparisons were revealed strain uniformity in C. trachomatis but strain variation in N. gonorrhoeae along with pronounced genetic complexity in N. gonorrhoeae virulance factors. However, obtained results revealed absences of related genes for virulance factors in C. trachomatis despite the presence of coding sequences in strains, and absences of coding sequences in N. gonorrhoeae FA 1090 strain. Results also revealed limited amount of virulence factor classes for C. trachomatis contrary to extensive literature reports and multigenic factors in certain virulence factors in N. gonorrhoeae strains due to the presence of multiple coding sequences. Overall, this research was revealed potential targets for further genomics research and emphasized the need of embracing multi-omics approaches in clinical microbiology studies. Dünya Sağlık Örgütü'nün tahminlerine göre, Chlamydia trachomatis ve Neisseria gonorrhoeae, cinsel yolla bulaşan enfeksiyonların artan yaygınlığından sorumlu en önemli patojenik bakterilerden ikisidir. Bu iki bakteri, halk sağlığı sorunlarında en ciddi zorluklar olarak defalarca rapor edilmiştir. Her iki bakteri de benzer enfeksiyon bölgelerine ve klinik özetlere sahiptir ve farklı filumlardan olmalarına ve farklı yaşam döngülerine sahip olmalarına rağmen, birlikte enfeksiyonlar için rapor edilmiştir. Kapsamlı araştırmalar, bu bakteriler için çeşitli virülans faktörlerini ortaya koymuş ve her birinin yaşam döngüsüne ve hayatta kalmasına uygun farklı virülans faktörü sınıflarına sahip olduğunu göstermiştir. Bu araştırmada, Çin'deki Ulusal Patojen Biyolojisi Enstitüsü'nün Virülans Faktörü Veritabanı'nda bulunan C. trachomatis ve N. gonorrhoeae'nin seçilmiş suşları, proteom tabanlı cins içi karşılaştırma için kullanıldı ve bu da iki tür arasında virülans faktörü sınıfı farklılığını ortaya çıkardı. Karşılaştırmalar, C. trachomatis'te suş homojenliğini, N. gonorrhoeae'de ise suş varyasyonunu ve N. gonorrhoeae virülans faktörlerinde belirgin genetik karmaşıklığı ortaya koydu. Ancak elde edilen sonuçlar, suşlarda kodlama dizilerinin varlığına rağmen C. trachomatis'te virülans faktörleriyle ilgili genlerin bulunmadığını ve N. gonorrhoeae FA 1090 suşunda kodlama dizilerinin bulunmadığını ortaya koymuştur. Sonuçlar ayrıca, kapsamlı literatür raporlarının aksine C. trachomatis için sınırlı sayıda virülans faktörü sınıfı ve N. gonorrhoeae suşlarında birden fazla kodlama dizisinin varlığı nedeniyle bazı virülans faktörlerinde çok genli faktörler olduğunu göstermiştir. Genel olarak, bu araştırma, daha ileri genomik araştırmalar için potansiyel hedefleri ortaya koymuş ve klinik mikrobiyoloji çalışmalarında çoklu omik yaklaşımların benimsenmesinin gerekliliğini vurgulamıştır.
- Open Access
- 30 June 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (2) , 348-359
Network Pharmacology-Based Approach to Unveil the Therapeutic Mechanism of Viburnum opulus L. on Glomerulonephritis
This study aimed to investigate the potential targets and pathways of the bioactive compounds of Viburnum opulus L. – a plant recognized in ethnopharmacology for its therapeutic applications in renal disorders - on glomerulonephritis (GN) disease. The phytochemical profile of V. opulus was obtained from review articles in the literature on plant contents. GN-associated target genes were retrieved from the GeneCards database, and interaction mapping was conducted using Cytoscape 3.10.0. The intersection of compound - target - disease was imported into the STRING database to create a PPI network. GO and KEGG enrichment analyses were applied to define the biological functions of the targets. A molecular docking study simulated the binding capabilities of key targets and active ingredients. A total of 9 bioactive constituents were identified from V. opulus, with rutin and quercetin demonstrating the highest binding affinities. The resulting compound–target interaction network consisted of 125 nodes and 358 edges. Central hub proteins within the PPI network included TP53, SRC, and EGFR indicating their potential role in the mechanism of action. GO and KEGG analyses suggested that the treatment of GN by V. opulus mainly involves the generation of cellular response to chemical and oxidative stress, protein tyrosine kinase activity, transcription regulatory complex, and other biological processes. The results of KEGG enrichment analysis indicate that V. opulus mainly involves some pathways, such as chemical carcinogenesis-receptor activation, EGFR tyrosine kinase inhibitor resistance in the treatment of GN. Molecular docking data presented that rutin and quercetin have the highest affinity score with TP53, SRC, and EGFR proteins. Overall, this study reveals the active compounds and potential molecular pathways of V. opulus in the treatment of GN and presents a source for further basic studies.
- 30 June 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (2) , 348-359
Open AccessNetwork Pharmacology-Based Approach to Unveil the Therapeutic Mechanism of Viburnum opulus L. on Glomerulonephritis
This study aimed to investigate the potential targets and pathways of the bioactive compounds of Viburnum opulus L. – a plant recognized in ethnopharmacology for its therapeutic applications in renal disorders - on glomerulonephritis (GN) disease. The phytochemical profile of V. opulus was obtained from review articles in the literature on plant contents. GN-associated target genes were retrieved from the GeneCards database, and interaction mapping was conducted using Cytoscape 3.10.0. The intersection of compound - target - disease was imported into the STRING database to create a PPI network. GO and KEGG enrichment analyses were applied to define the biological functions of the targets. A molecular docking study simulated the binding capabilities of key targets and active ingredients. A total of 9 bioactive constituents were identified from V. opulus, with rutin and quercetin demonstrating the highest binding affinities. The resulting compound–target interaction network consisted of 125 nodes and 358 edges. Central hub proteins within the PPI network included TP53, SRC, and EGFR indicating their potential role in the mechanism of action. GO and KEGG analyses suggested that the treatment of GN by V. opulus mainly involves the generation of cellular response to chemical and oxidative stress, protein tyrosine kinase activity, transcription regulatory complex, and other biological processes. The results of KEGG enrichment analysis indicate that V. opulus mainly involves some pathways, such as chemical carcinogenesis-receptor activation, EGFR tyrosine kinase inhibitor resistance in the treatment of GN. Molecular docking data presented that rutin and quercetin have the highest affinity score with TP53, SRC, and EGFR proteins. Overall, this study reveals the active compounds and potential molecular pathways of V. opulus in the treatment of GN and presents a source for further basic studies.
- Open Access
- 29 June 2025
- Published by Wah Academia (SMC-PVT) Ltd in Wah Academia Journal of Health and Nutrition
- Vol. 1 (2) , 27-32
Aynısafa Bitkisi (Calendula officinalis L.) Fitobileşenlerinin Siklooksijenaz-2 Enzimi Üzerine Etkisinin İn Siliko İncelenmesi
Nonsteroidal antiiflamatuvar ilaçlar (NSAİİ), analjezik, antipiretik ve antiinflamatuvar etkiye sahip olup, siklooksijenaz – 2 (COX-2) enzim inhibisyonu yoluyla bu etkileri gösterdikleri belirlenmiştir. Birçok klinik çalışma sonucunda NSAİİ’lerin gastrointestinal ve kardiyovasküler yan etkiler oluşturduğu bulunmuştur. Aynısafa bitksi (Calendula officinalis L.) Asteraceae familyasından bir bitkidir. Bu bitkinin halk tıbbında oldukça sık kullanıldığı ve antitümör, antioksidan, antifungal, antiviral, antiinflamatuvar, antibakteriyel aktiviteler gösterdiği bilinmektedir. Mevcut literatürde Calendula bitkisine ait içerik raporları incelenmiştir (https://phytochem.nal.usda.gov/). Bu çalışma kapsamında moleküler docking çalışması için bitkinin 1,4-Phthalazinedione; Metanephrine bis (trimethylsilyl) ether; Alpha-Cubebene; Beta-Copaene; Nitro-2H-chromene; Beta-Guaiene; Gamma-Muurolene; Isofucosterol, 5-Phytyltoluquınone gibi etken moleküller seçilmiştir. Protein Data Bank (PDB)’den çekilen COX-2 enziminin yapısı moleküler kenetleme (moleküler docking) analizleri ile değerlendirilmiş ve fitokimyasallar ile hedef proteinlerin etkileşimleri belirlenmiştir. Validasyon işlemi için redocking yapılmıştır. PDB (Protein Data Bank) da COX-2 enzimini en iyi temsil edecek şekilde 5KIR yapısı seçilmiştir. Nonsteroidal anti-inflammatory drugs (NSAIDs) possess analgesic, antipyretic, and anti-inflammatory effects, which have been shown to occur through inhibition of the cyclooxygenase-2 (COX-2) enzyme. However, numerous clinical studies have reported that NSAIDs can cause gastrointestinal and cardiovascular side effects. Marigold (Calendula officinalis L.) is a plant belonging to the Asteraceae family. It is widely used in traditional medicine and is known to exhibit antitumor, antioxidant, antifungal, antiviral, anti-inflammatory, and antibacterial activities. In the current study, reports on the phytochemical content of Calendula were reviewed (https://phytochem.nal.usda.gov/). For molecular docking analyses, bioactive compounds of the plant, including 1,4-Phthalazinedione; Metanephrine bis(trimethylsilyl) ether; Alpha-Cubebene; Beta-Copaene; Nitro-2H-chromene; Beta-Guaiene; Gamma-Muurolene; Isofucosterol; and 5-Phytyltoluquinone, were selected. The COX-2 enzyme structure obtained from the Protein Data Bank (PDB) was evaluated using molecular docking analyses to determine the interactions between these phytochemicals and the target protein. Redocking was performed for validation purposes, and the PDB structure 5KIR was selected as the most representative structure of the COX-2 enzyme.
- 29 June 2025
- Published by Wah Academia (SMC-PVT) Ltd in Wah Academia Journal of Health and Nutrition
- Vol. 1 (2) , 27-32
Open AccessAynısafa Bitkisi (Calendula officinalis L.) Fitobileşenlerinin Siklooksijenaz-2 Enzimi Üzerine Etkisinin İn Siliko İncelenmesi
Nonsteroidal antiiflamatuvar ilaçlar (NSAİİ), analjezik, antipiretik ve antiinflamatuvar etkiye sahip olup, siklooksijenaz – 2 (COX-2) enzim inhibisyonu yoluyla bu etkileri gösterdikleri belirlenmiştir. Birçok klinik çalışma sonucunda NSAİİ’lerin gastrointestinal ve kardiyovasküler yan etkiler oluşturduğu bulunmuştur. Aynısafa bitksi (Calendula officinalis L.) Asteraceae familyasından bir bitkidir. Bu bitkinin halk tıbbında oldukça sık kullanıldığı ve antitümör, antioksidan, antifungal, antiviral, antiinflamatuvar, antibakteriyel aktiviteler gösterdiği bilinmektedir. Mevcut literatürde Calendula bitkisine ait içerik raporları incelenmiştir (https://phytochem.nal.usda.gov/). Bu çalışma kapsamında moleküler docking çalışması için bitkinin 1,4-Phthalazinedione; Metanephrine bis (trimethylsilyl) ether; Alpha-Cubebene; Beta-Copaene; Nitro-2H-chromene; Beta-Guaiene; Gamma-Muurolene; Isofucosterol, 5-Phytyltoluquınone gibi etken moleküller seçilmiştir. Protein Data Bank (PDB)’den çekilen COX-2 enziminin yapısı moleküler kenetleme (moleküler docking) analizleri ile değerlendirilmiş ve fitokimyasallar ile hedef proteinlerin etkileşimleri belirlenmiştir. Validasyon işlemi için redocking yapılmıştır. PDB (Protein Data Bank) da COX-2 enzimini en iyi temsil edecek şekilde 5KIR yapısı seçilmiştir. Nonsteroidal anti-inflammatory drugs (NSAIDs) possess analgesic, antipyretic, and anti-inflammatory effects, which have been shown to occur through inhibition of the cyclooxygenase-2 (COX-2) enzyme. However, numerous clinical studies have reported that NSAIDs can cause gastrointestinal and cardiovascular side effects. Marigold (Calendula officinalis L.) is a plant belonging to the Asteraceae family. It is widely used in traditional medicine and is known to exhibit antitumor, antioxidant, antifungal, antiviral, anti-inflammatory, and antibacterial activities. In the current study, reports on the phytochemical content of Calendula were reviewed (https://phytochem.nal.usda.gov/). For molecular docking analyses, bioactive compounds of the plant, including 1,4-Phthalazinedione; Metanephrine bis(trimethylsilyl) ether; Alpha-Cubebene; Beta-Copaene; Nitro-2H-chromene; Beta-Guaiene; Gamma-Muurolene; Isofucosterol; and 5-Phytyltoluquinone, were selected. The COX-2 enzyme structure obtained from the Protein Data Bank (PDB) was evaluated using molecular docking analyses to determine the interactions between these phytochemicals and the target protein. Redocking was performed for validation purposes, and the PDB structure 5KIR was selected as the most representative structure of the COX-2 enzyme.
- Open Access
- 27 April 2025
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 13 (4) , 882-887
Determination of the Bioavailability of Arum maculatum L. Plant Extracts in Caenorhabditis elegans Culture
Plants are used by humans not only as food, but also for therapeutic purposes in medicine, as fuel and coloring matter. Plants, which are among the natural products consumed as traditional medicines, are used in the treatment of many diseases. Nowadays, many plants are widely used as nutritional supplements to strengthen the immune system or as an auxiliary nutritional supplement with other drugs in the treatment of chronic diseases. The plant Arum maculatum L. examined in this study is an angiosperm and monocotyledonous plant belonging to the family Araceae and a species in the order Arales. In this study it is aimed to study the bioavailability of Arum plant by using C. elegans nematode as a model organism. This study, the effects of the extract obtained by ethyl alcohol and water phase extraction of A. maculatum L., which is collected in spring and summer months and consumed by cooking fresh leaves and believed to be a source of healing, on the life span, egg production and growth-development parameters of Caenorhabditis elegans nematode were investigated. The data obtained were evaluated by SPSS program. Significant differences were found in C. elegans cultures of the extracts obtained from the leaves and flower parts of the plant in ethyl alcohol and water solvents compared to the control group. It was observed that the survival rates of C. elegans nematodes generally increased with the application of different doses of plant water extracts. This research will provide a reference for further research on the mechanism of Arum plants in the treatment of some diseases. Our research shows that this plant may have the potential therapeutic target about fertilization and growth and development process.
- 27 April 2025
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 13 (4) , 882-887
Open AccessDetermination of the Bioavailability of Arum maculatum L. Plant Extracts in Caenorhabditis elegans Culture
Plants are used by humans not only as food, but also for therapeutic purposes in medicine, as fuel and coloring matter. Plants, which are among the natural products consumed as traditional medicines, are used in the treatment of many diseases. Nowadays, many plants are widely used as nutritional supplements to strengthen the immune system or as an auxiliary nutritional supplement with other drugs in the treatment of chronic diseases. The plant Arum maculatum L. examined in this study is an angiosperm and monocotyledonous plant belonging to the family Araceae and a species in the order Arales. In this study it is aimed to study the bioavailability of Arum plant by using C. elegans nematode as a model organism. This study, the effects of the extract obtained by ethyl alcohol and water phase extraction of A. maculatum L., which is collected in spring and summer months and consumed by cooking fresh leaves and believed to be a source of healing, on the life span, egg production and growth-development parameters of Caenorhabditis elegans nematode were investigated. The data obtained were evaluated by SPSS program. Significant differences were found in C. elegans cultures of the extracts obtained from the leaves and flower parts of the plant in ethyl alcohol and water solvents compared to the control group. It was observed that the survival rates of C. elegans nematodes generally increased with the application of different doses of plant water extracts. This research will provide a reference for further research on the mechanism of Arum plants in the treatment of some diseases. Our research shows that this plant may have the potential therapeutic target about fertilization and growth and development process.
- 30 January 2025
- Published by Gaziantep Islam Science and Technology University - Vocational School of Health Services in GISTU Journal of Health and Biological Sciences
- Vol. 1 (1) , 9-21
Investigation of the Interaction of Phytochemical Compounds in Vitis vinifera L. with Human Hemoglobin Protein by Molecular Docking Method
Purpose: Hemoglobin is a protein found in red blood cells that carries oxygen to tissues and is an important marker, especially in the diagnosis of anemia. Vitis vinifera is a plant that is reported to be beneficial for anemia due to its rich content of phytochemical compounds. This study aimed to investigate the interactions between the active compounds in Vitis vinifera and hemoglobin protein using the molecular docking method. Methods: The Maestro Schrödinger software package was utilized to calculate the binding affinity of the plant's active compounds to the hemoglobin protein. The molecular structures of the ligands were retrieved from the PubChem database, while the hemoglobin protein structure (PDB ID: 2D60) was obtained from the RCSB Protein Data Bank. Results: In this study, the interactions between 16 active compounds of V. vinifera and hemoglobin protein were analyzed. The phytochemical components with the highest binding affinities to hemoglobin protein were identified as vitisin A (-9.144 kcal/mol), proanthocyanidin (-7.791 kcal/mol), and anthocyanin a2 (-7.356 kcal/mol). Conclusion: This study demonstrated the interactions between human hemoglobin protein and phytochemical compounds in Vitis vinifera using molecular docking binding scores. The low binding energies of Vitisin A, proanthocyanidin, and anthocyanin a2 indicate the potential of these compounds to act as binders for the hemoglobin protein.
- 30 January 2025
- Published by Gaziantep Islam Science and Technology University - Vocational School of Health Services in GISTU Journal of Health and Biological Sciences
- Vol. 1 (1) , 9-21
Investigation of the Interaction of Phytochemical Compounds in Vitis vinifera L. with Human Hemoglobin Protein by Molecular Docking Method
Purpose: Hemoglobin is a protein found in red blood cells that carries oxygen to tissues and is an important marker, especially in the diagnosis of anemia. Vitis vinifera is a plant that is reported to be beneficial for anemia due to its rich content of phytochemical compounds. This study aimed to investigate the interactions between the active compounds in Vitis vinifera and hemoglobin protein using the molecular docking method. Methods: The Maestro Schrödinger software package was utilized to calculate the binding affinity of the plant's active compounds to the hemoglobin protein. The molecular structures of the ligands were retrieved from the PubChem database, while the hemoglobin protein structure (PDB ID: 2D60) was obtained from the RCSB Protein Data Bank. Results: In this study, the interactions between 16 active compounds of V. vinifera and hemoglobin protein were analyzed. The phytochemical components with the highest binding affinities to hemoglobin protein were identified as vitisin A (-9.144 kcal/mol), proanthocyanidin (-7.791 kcal/mol), and anthocyanin a2 (-7.356 kcal/mol). Conclusion: This study demonstrated the interactions between human hemoglobin protein and phytochemical compounds in Vitis vinifera using molecular docking binding scores. The low binding energies of Vitisin A, proanthocyanidin, and anthocyanin a2 indicate the potential of these compounds to act as binders for the hemoglobin protein.
- Open Access
- 1 January 2025
- Published by Gaziantep Islam Science and Technology University in Experimental and Applied Medical Science
- Vol. 6 (2) , 146-148
Decoding Biological Networks: A Network Pharmacology Approach Powered by Artificial Intelligence
In recent years, significant advances have been made in elucidating the complex structure of biological systems and understanding diseases at the molecular level. These advances have shown that drug development strategies focusing on a single target are often inadequate in the treatment of complex diseases in which multiple genetic and environmental factors have a major impact . This has increased the importance of multidisciplinary approaches and led the scientific world to seek more holistic models. Systems biology-based approaches are gaining more and more importance, and the concept of network pharmacology, which evaluates the intrinsic dynamics of biological systems through networks, including multi-component, multi-target and multi-level analyzes, is coming to the fore. Network pharmacology has become a strategic tool in today's drug discovery processes, especially because it provides the opportunity to evaluate gene, protein and drug interactions at multiple levels. However, for this approach to be used efficiently, large and complex datasets need to be processed. At this point, the possibilities offered by artificial intelligence come into play. Artificial intelligence, especially machine learning and deep learning techniques, make the analysis of biological data much more meaningful and faster. Modeling processes that could take months with traditional methods can now be done in minutes. However, artificial intelligence has become not only an accelerator, but also a tool that can establish new relationships, make predictions and generate hypotheses. Network pharmacology aims to analyze the interactions of genes, proteins, metabolites, etc. through networks. However, these networks are often very large and complex, so classical statistical approaches may be insufficient. The role of artificial intelligence at this point is critical. Especially in studies conducted in countries with a strong traditional medicine background such as China and India, the effects of herbal compounds on the network have been systematically mapped with the help of artificial intelligence. Similarly, evaluating the ethnobotanical knowledge widespread in Anatolia with these methods can make important contributions to both the preservation of cultural heritage and the discovery of potential therapeutic candidates. Although the potential of AI-enabled network pharmacology is high, there are some challenges that slow the progress of this field. First of all, the decision processes of AI algorithms are often “black box” in nature, meaning that they have limited explainability, making biological interpretation difficult. Moreover, the quality, standardization and reliability of the data are factors that directly affect model performance. In particular, noise and missing data problems, which are frequently encountered in -omics data sets, can reduce the reliability of AI models. Another important aspect is the need for interdisciplinary collaboration. Developing a common language between biologists, computer scientists, pharmacologists and clinicians is critical for the successful implementation of these models. In this context, issues such as platforms that encourage open data sharing, the development of modular and explainable artificial intelligence models, and ensuring data security within the framework of ethical rules are expected to be more on the agenda in the coming years. Network pharmacology approaches supported by artificial intelligence pioneer the understanding of disease mechanisms at the system level and the development of effective treatment strategies. Especially in the modeling of multi-target and multi-component therapies, this approach offers more holistic and effective solutions compared to classical methods . This interdisciplinary field has great potential in terms of scientifically analyzing complex therapeutic elements such as herbal products, developing individualized medicine practices and accelerating drug discovery processes. Through this letter, I hope that more researchers will embrace, support and strengthen international collaborations in this powerful approach that combines artificial intelligence and network pharmacology.
- 1 January 2025
- Published by Gaziantep Islam Science and Technology University in Experimental and Applied Medical Science
- Vol. 6 (2) , 146-148
Open AccessDecoding Biological Networks: A Network Pharmacology Approach Powered by Artificial Intelligence
In recent years, significant advances have been made in elucidating the complex structure of biological systems and understanding diseases at the molecular level. These advances have shown that drug development strategies focusing on a single target are often inadequate in the treatment of complex diseases in which multiple genetic and environmental factors have a major impact . This has increased the importance of multidisciplinary approaches and led the scientific world to seek more holistic models. Systems biology-based approaches are gaining more and more importance, and the concept of network pharmacology, which evaluates the intrinsic dynamics of biological systems through networks, including multi-component, multi-target and multi-level analyzes, is coming to the fore. Network pharmacology has become a strategic tool in today's drug discovery processes, especially because it provides the opportunity to evaluate gene, protein and drug interactions at multiple levels. However, for this approach to be used efficiently, large and complex datasets need to be processed. At this point, the possibilities offered by artificial intelligence come into play. Artificial intelligence, especially machine learning and deep learning techniques, make the analysis of biological data much more meaningful and faster. Modeling processes that could take months with traditional methods can now be done in minutes. However, artificial intelligence has become not only an accelerator, but also a tool that can establish new relationships, make predictions and generate hypotheses. Network pharmacology aims to analyze the interactions of genes, proteins, metabolites, etc. through networks. However, these networks are often very large and complex, so classical statistical approaches may be insufficient. The role of artificial intelligence at this point is critical. Especially in studies conducted in countries with a strong traditional medicine background such as China and India, the effects of herbal compounds on the network have been systematically mapped with the help of artificial intelligence. Similarly, evaluating the ethnobotanical knowledge widespread in Anatolia with these methods can make important contributions to both the preservation of cultural heritage and the discovery of potential therapeutic candidates. Although the potential of AI-enabled network pharmacology is high, there are some challenges that slow the progress of this field. First of all, the decision processes of AI algorithms are often “black box” in nature, meaning that they have limited explainability, making biological interpretation difficult. Moreover, the quality, standardization and reliability of the data are factors that directly affect model performance. In particular, noise and missing data problems, which are frequently encountered in -omics data sets, can reduce the reliability of AI models. Another important aspect is the need for interdisciplinary collaboration. Developing a common language between biologists, computer scientists, pharmacologists and clinicians is critical for the successful implementation of these models. In this context, issues such as platforms that encourage open data sharing, the development of modular and explainable artificial intelligence models, and ensuring data security within the framework of ethical rules are expected to be more on the agenda in the coming years. Network pharmacology approaches supported by artificial intelligence pioneer the understanding of disease mechanisms at the system level and the development of effective treatment strategies. Especially in the modeling of multi-target and multi-component therapies, this approach offers more holistic and effective solutions compared to classical methods . This interdisciplinary field has great potential in terms of scientifically analyzing complex therapeutic elements such as herbal products, developing individualized medicine practices and accelerating drug discovery processes. Through this letter, I hope that more researchers will embrace, support and strengthen international collaborations in this powerful approach that combines artificial intelligence and network pharmacology.